Nervgen Pharma (NGEN) traded up 0.7 % during a 24 hours period ending at 03:51 PM Central Europe on Monday 26th. One Nervgen Pharma stock can currently be bought for about USD 1.4 on popular exchanges. Current supply of Nervgen Pharma stocks is 107.5 mn. Nervgen Pharma has a current market capitalization of USD 153.8 mn and approximately USD 1.3 mn worth of Nervgen Pharma was traded on exchanges in the last 24 hours. Since last month end, Nervgen Pharma has traded -29.21 % down. Simple moving average of last 200 days is at USD 2.95. The highest price of past 52 weeks was recorded at USD 6.3 on 01/08/2026. 52 weeks low was at USD 1.38 on 10/23/2026.
Here is how related stocks have performed in the past 24 hours:
Terrascend (TSND.TO) traded down -4.35 % and now trades at CAD 0.67. Terrascend has a market capitalisation of CAD 257.1 mn.
Bonterra Energy (BNE.TO) traded up 5.74 % and now trades at CAD 6.78. Bonterra Energy has a market capitalisation of CAD 245 mn.
Errington Metals (EM.V) traded down -3.23 % and now trades at CAD 4.59. Current market capitalisation for Errington Metals is CAD 250.9 mn.
Sandfire America I (SFR.V) traded flat 0 % and now trades at CAD 0.25. Sandfire America I has a market capitalisation of CAD 255.8 mn.
Alpha Cognition (ACOG) traded up 0.36 % and now trades at USD 8.32. Alpha Cognition has a market capitalisation of USD 181.6 mn.
About Nervgen Pharma
NervGen Pharma Corp. is a biotech company based in Vancouver, Canada. The company specializes in developing drugs for the treatment of spinal cord injury, multiple sclerosis, Alzheimer’s disease, nerve damage, and neurodegenerative diseases. NervGen Pharma exclusively serves clients in Canada and can be accessed through their website at www.nervgen.com . The company is listed on the TSX Venture Exchange.
